Elif Soyak Aytekin

Elif Soyak Aytekin

Auto-generated profile, based on publicly available information

Elif Soyak Aytekin

Division of Pediatric Immunology, Department of Pediatrics Hacettepe University Medical School Ankara Türkiye

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 May 2021 in Scandinavian Journal of Immunology
Verified
Journal Article
Closed access
PDF file
EAElif Soyak Aytekin
Elif Soyak Aytekin
AKArmagan Keskin
Armagan Keskin
CTCagman Tan
Cagman Tan
EYEbru Yalçın
Ebru Yalçın
DDDeniz Dogru
Deniz Dogru
DCDeniz Cagdas
Deniz Cagdas

5 August 2021 in Clinical and Experimental Immunology
Verified
Journal Article
Open access
PDF file
IYIsmail Yaz
Ismail Yaz
BOBegum Ozbek
Begum Ozbek
HBHacer Neslihan Bildik
Hacer Neslihan Bildik
CTCagman Tan
Cagman Tan
SHSevil Oskay Halaçlı
Sevil Oskay Halaçlı
ITIlhan Tezcan
Ilhan Tezcan
Leukocyte adhesion deficiency type I is a rare primary immunodeficiency disorder characterized by mutations in the ITGB2 gene encoding CD18. We present clinical and immunological features of 15 patients with leukocyte adhesion deficiency type 1 (LAD-1). Targeted next-generation sequencing was performed with either a primary immunodeficiency gene panel comprising 266 genes or a small LAD-panel consisting of five genes for genetic analysis. To measure the expression level of integrins on the leukocyte surface, flow cytometry analysis was performed. The median age of the patients at diagnosis was 3 (1–48) months. Eleven (73%) of the 15 patients had a LAD-1 diagnosis in their first 6 months and 14 (93%) patients had consanguineous parents. Delayed separation of the umbilical cord was present in 80% (n = 12) of the patients in our cohort, whereas omphalitis was observed in 53% (n = 8) of the patients. Leukocytosis with neutrophil predominance was observed in 73% (n = 11) patients. Nine distinct variants in the ITGB2 gene in 13 of the 15 patients with LAD-1 were characterized, two of which (c.305_306delAA and c.779_786dup) are novel homozygous mutations of ITGB2. Four unrelated patients from Syria had a novel c.305_306delAA mutation that might be a founder effect for patients of Syrian origin. Four (27%) patients underwent hematopoietic stem cell transplantation. Two patients died because of HSCT complications and the other two are alive and well. Early differential diagnosis of the patients is critical in the management of the disease and genetic evaluation provides a basis for family studies and genetic counseling.

14 May 2022 in Pediatric Pulmonology
Verified
Journal Article
Closed access
EAElif Soyak Aytekin
Elif Soyak Aytekin
USUmit M. Sahiner
Umit M. Sahiner
SDSevda Tuten Dal
Sevda Tuten Dal
HUHilal Unsal
Hilal Unsal
OHOzan Hakverdi
Ozan Hakverdi
OSOzge Soyer
Ozge Soyer

12 April 2023 in European Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
PGPınar Gür-Çetinkaya
Pınar Gür-Çetinkaya
EAElif Soyak Aytekin
Elif Soyak Aytekin
SESaliha Esenboga
Saliha Esenboga
DCDeniz Cagdas
Deniz Cagdas
ÜŞümit şahiner
ümit şahiner
OSOzge Soyer
Ozge Soyer

18 April 2022 in Pediatric Allergy and Immunology
Verified
Journal Article
Closed access
EAElif Soyak Aytekin
Elif Soyak Aytekin
HUHilal Unsal
Hilal Unsal
USUmit Murat Sahiner
Umit Murat Sahiner
OSOzge Soyer
Ozge Soyer
BSBulent Sekerel
Bulent Sekerel

12 June 2023 in Scandinavian Journal of Immunology
Verified
Journal Article
Closed access
EAElif Soyak Aytekin
Elif Soyak Aytekin
DCDeniz Cagdas
Deniz Cagdas